Topline results of a Phase II trial reveal that VX-993 did not meet its primary endpoints, meaning Vertex will discontinue its development.

India was slapped with an additional set of tariffs at the rate of 15 per cent tariffs making the total tariff for India 25 ...

The United States 25 per cent tariff on Indian imports is set to take effect on August 7. PHDCCI projected that the tariffs can impact the import of engineering goods ($1.8 billion), electronic goods ...

These tariffs would drastically undermine the price advantage Indian drug makers currently enjoy in the US, especially in ...

The 39% punitive tariffs threatened by U.S. President Donald Trump have caused an uproar in Switzerland. But how important ...

Novo Nordisk is to cut costs as the Wegovy-maker battles competition from rival Eli Lilly and copycat versions of its obesity ...

The US government has long sought to shift pharmaceutical manufacturing back to domestic soil, citing both economic and ...

TotalEnergies Marketing India Private Limited (TEMIPL) announces the launch of its new and improved range of Quartz car ...

The regulatory environment is placing extreme pricing pressure on pharmaceutical manufacturers. Their success in the market ...

All three major U.S. indexes finished in the red, after a disappointing services-sector report and tariff news weighed on investor sentiment. The ISM services-sector index provided another sign that ...

Donald Trump plans to impose new tariffs on pharmaceuticals and semiconductors to boost manufacturing in the US.

Discover key insights from Personalis Inc.'s Q2 2025 earnings call, including clinical growth, NeXT Personal adoption, Tempus partnership, and ...